1,887 Shares of CME Group Inc. $CME Acquired by BOS Asset Management LLC

BOS Asset Management LLC acquired a new position in CME Group Inc. (NASDAQ:CME) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,887 shares of the financial services provider’s stock, valued at approximately $494,000.

Several other institutional investors also recently bought and sold shares of CME. Bridgewater Advisors Inc. purchased a new stake in shares of CME Group in the second quarter valued at approximately $612,000. The Manufacturers Life Insurance Company purchased a new position in shares of CME Group during the 2nd quarter valued at approximately $53,671,000. Haverford Trust Co acquired a new stake in CME Group in the 2nd quarter valued at $13,818,000. Bowie Capital Management LLC purchased a new stake in CME Group in the 2nd quarter worth $22,991,000. Finally, GSA Capital Partners LLP purchased a new stake in CME Group in the 2nd quarter worth $2,807,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other CME Group news, Director William Shepard acquired 293 shares of the stock in a transaction that occurred on Friday, September 25th. The shares were purchased at an average cost of $268.76 per share, with a total value of $78,746.68. Following the purchase, the director owned 263,289 shares in the company, valued at approximately $70,761,551.64. The trade was a 0.11% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Elizabeth Cook sold 500 shares of the company’s stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $280.11, for a total transaction of $140,055.00. Following the completion of the sale, the director directly owned 17,916 shares in the company, valued at $5,018,450.76. This trade represents a 2.72% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have issued reports on CME. Deutsche Bank Aktiengesellschaft downgraded shares of CME Group from a “buy” rating to a “hold” rating and decreased their price objective for the company from $286.00 to $270.00 in a report on Wednesday, August 19th. Piper Sandler decreased their price target on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 15th. Bank of America lifted their price objective on CME Group from $226.00 to $230.00 and gave the stock an “underperform” rating in a report on Thursday, July 23rd. Raymond James Financial reiterated an “outperform” rating and set a $320.00 price objective on shares of CME Group in a research note on Thursday, July 2nd. Finally, Wall Street Zen upgraded CME Group from a “strong sell” rating to a “sell” rating in a research report on Saturday, October 3rd. Eight equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $292.06.

CME Group Price Performance

NASDAQ CME traded up $2.47 during trading hours on Friday, hitting $278.91. 1,027,292 shares of the company’s stock traded hands, compared to its average volume of 2,524,912. The company has a market capitalization of $100.29 billion, a PE ratio of 23.66, a PEG ratio of 3.54 and a beta of 0.24. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 52-week low of $218.31 and a 52-week high of $329.16. The firm’s 50-day moving average is $271.81 and its 200-day moving average is $271.19.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.08. The business had revenue of $1.71 billion for the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The business’s revenue for the quarter was up .8% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.96 EPS. Equities analysts forecast that CME Group Inc. will post 12.28 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 25th. Investors of record on Wednesday, September 9th were issued a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend was Wednesday, September 9th. CME Group’s dividend payout ratio is currently 44.11%.

CME Group Company Profile

CME Group Inc operates global derivatives marketplaces that enable customers to manage risk and trade futures and options contracts. Its exchanges offer products linked to interest rates, equity indexes, foreign currencies, agricultural commodities, energy, metals and other asset classes.

The company also provides central counterparty clearing, settlement and related risk-management services for transactions conducted on its markets. In addition, CME Group offers market data, benchmark products and technology services that support trading, analysis and connectivity for financial institutions, businesses, professional traders and other market participants.

CME Group’s history includes the Chicago Board of Trade, founded in 1848, and the Chicago Mercantile Exchange, established in 1898.